Follow
Jessica Lisle
Jessica Lisle
Mater Research
Verified email at mater.uq.edu.au
Title
Cited by
Cited by
Year
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
V Barbier, J Erbani, C Fiveash, JM Davies, J Tay, MR Tallack, J Lowe, ...
Nature communications 11 (1), 2042, 2020
1332020
Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin‐B2 ligand
R Rutkowski, I Mertens‐Walker, JE Lisle, AC Herington, SA Stephenson
International journal of cancer 131 (5), 2012
742012
Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer
JE Lisle, I Mertens-Walker, R Rutkowski, AC Herington, SA Stephenson
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1835 (2), 243-257, 2013
492013
Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4
SA Stephenson, EL Douglas, I Mertens-Walker, JE Lisle, MSN Maharaj, ...
Oncotarget 6 (10), 7554, 2015
292015
Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer
JE Lisle, I Mertens-Walker, CR Stephens, SH Stansfield, JA Clements, ...
Experimental Cell Research 333 (1), 136-146, 2015
152015
Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases
Y Dong, BS Harrington, MN Adams, A Wortmann, SA Stephenson, J Lisle, ...
Biological Chemistry 395 (9), 977-990, 2014
132014
EphB4 localises to the nucleus of prostate cancer cells
I Mertens-Walker, JE Lisle, WA Nyberg, CR Stephens, L Burke, ...
Experimental Cell Research 333 (1), 105-115, 2015
82015
Inhibiting Eph kinase activity may not be “Eph” ective for cancer treatment
AC Herington, I Mertens-Walker, JE Lisle, M Maharaj, SA Stephenson
Growth Factors 32 (6), 207-213, 2014
62014
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
JR Lydeard, MI Lin, HG Ge, A Halfond, S Wang, MB Jones, J Etchin, ...
Molecular Therapy-Methods & Clinical Development 31, 2023
12023
Knock out of CD123 or CLL-1 By CRISPR-Cas9 Editing from Human Hematopoietic Stem Cell Transplants Provide New Possibilities for Increasing Therapeutic Index and Safety for AML …
C Luo, G Angelini, S Krishnamurthy, J Lisle, M Isik, A Ghdossi, ...
Blood 138, 3818, 2021
12021
Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression
AC Pliego Zamora, H Ranasinghe, JE Lisle, CK Ng, S Huang, R Wadlow, ...
Cancers 13 (15), 3858, 2021
12021
CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in …
J Lisle, S Krishnamurthy, A Halfond, L Pechilis, N Manalo, M Chng, ...
Blood 142, 3425, 2023
2023
Multiplex Engineering of Human CD34+ HSPCs Enables Dual Gene Knock-out While Maintaining High Engraftment Potential and Safety
N Patel, M Pettiglio, C Cummins, J Pimentel, A Kapuria, A Ghodssi, M Isik, ...
Blood 138, 2939, 2021
2021
EPHA3 IS DISPENSABLE FOR NUP98-HOXD13-DRIVEN ACUTE MYELOID LEUKAEMIA BUT CRITICAL FOR NORMAL HAEMATOPOIETIC STEM CELL FUNCTION
C Slape, J Lisle, AP Zamora, R Wadlow, S Huang
Experimental Hematology 76, S85, 2019
2019
CELL-EXTRINSIC EFFECTS IN T CELL PRE-LEUKEMIA STEM CELLS
AP Zamora, H Ranasinghe, J Lisle, S Huang, C Slape
Experimental Hematology 76, S82, 2019
2019
Serial Transplantation of Pre-Leukemic T-ALL Stem Cells Requires EphA3
AP Zamora, H Ranasinghe, J Lisle, C Slape
Experimental Hematology 64, S104, 2018
2018
Variation in HoxA9 Expression in the NUP98-HOXD13 Myelodysplasia Model, Using a Novel HoxA9-eGFP Reporter Mouse
C Slape, AP Zamora, J Lisle, J Huang, L Zhao, P Koopman
Experimental Hematology 64, S104, 2018
2018
Proteolysis of ephb4 in prostate cancer produces a bioactive intracellular domain fragment
A Herington, J Lisle, I Mertens-Walker, C Stephens, J Clements, ...
CLINICAL ENDOCRINOLOGY 86, 38-38, 2017
2017
Optimising conditions for studying the interaction between EphB4 positive prostate cancer cells and ephrin-B2 positive endothelial cells
A Protsenko, M Maharaj, J Lisle, A Herington, SA Stephenson
BJU INTERNATIONAL 118, 25-25, 2016
2016
Proteolytic regulation of the EphB4 receptor in Prostate Cancer; Does it produce bioactive cleavage fragments?
J Lisle, M Maharaj, I Mertens-Walker, C Stephens, S Stansfield, ...
CLINICAL & EXPERIMENTAL METASTASIS 32 (3), 218-219, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20